Indegene’s 17.67% margin trails healthcare peers in Q1FY27
Other income of Rs 33.9 cr was a material part of pre-tax profit, while management highlighted higher-value work and GenAI-led productivity.
Filed 30 Jul 2026, 18:50 IST · after market close · Indegene Ltd (INDGN)
Key takeaways
- Standalone Q1FY27 net profit was Rs 59.9 cr, with other income of Rs 33.9 cr against profit before tax of Rs 80.0 cr.
- Operating margin was 17.67%, 9.80 percentage points below the 27.47% median for 17 reported healthcare peers.
- Management said it is moving into higher-value creative and strategic work while embedding GenAI and agents into delivery workflows.
Price around the results
Q1 profit included a sizeable other-income contribution
Standalone operating profit of Rs 60.2 cr converted to net profit of Rs 59.9 cr after interest of Rs 2.7 cr, depreciation of Rs 11.4 cr and tax of Rs 20.1 cr. Other income of Rs 33.9 cr was a material contributor to profit before tax of Rs 80.0 cr, so reported earnings were not driven by operations alone. The results were filed after market close on 30 July 2026.
Indegene’s margin sits below the healthcare peer median
The company’s 17.67% operating margin was 9.80 percentage points below the 27.47% median among 17 healthcare peers that had reported the quarter. It ranked fifth from the bottom, placing its margin close to the lower end of the reported sector set.
Management linked the strategy to higher-value and AI-enabled work
Management said Indegene is moving upstream into creative, strategic and content-creation work to capture more higher-value assignments. The company also said it is embedding GenAI and agents into delivery workflows to improve productivity and operating leverage. Management said GenAI price deflation is pressuring large incumbents, while its AI-enabled solutions are taking wallet share from incumbents.
Q1FY27 at a glance
Standalone figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹341 cr |
| Other income | ₹34 cr |
| Expenses | ₹281 cr |
| Operating profit | ₹60 cr |
| Operating margin (%) | 17.67% |
| Interest | ₹3 cr |
| Depreciation | ₹11 cr |
| Profit before tax | ₹80 cr |
| Tax | ₹20 cr |
| Net profit | ₹60 cr |
| EPS (₹) | ₹2.49 |
Operating margin of 17.67% compares with a Healthcare sector median of 27.47% across 17 peers that have reported Q1FY27.
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
New initiatives
- The company is moving upstream into higher-value creative, strategic and content-creation work.
- The company is embedding GenAI and agents into delivery workflows to improve productivity and operating leverage.
Competition
- The company says its AI-enabled solutions are taking wallet share from incumbents.
Problems & risks
- The company says GenAI price deflation pressures large incumbents.
What to watch
- Whether operating margin moves above or below 17.67% in the next reported quarter.
- Whether operating profit increases from the standalone Q1FY27 base of Rs 60.2 cr.
- Whether other income remains near the Q1FY27 level of Rs 33.9 cr.